UPC
Universe Pharmaceuticals INC (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Price History
Fundamentals
| Market Cap | $3.53M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-8.06 |
| Dividend Yield | - |
| Profit Margin | -20.56% |
| Revenue Growth | -14.10% |
| ROE | -7.23% |
| Debt/Equity | 16.49 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 56.0 |
| Beta | 1.60 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $17.96 |
| 52-Week Low | $2.00 |
| 50-Day Avg | $3.33 |
| 200-Day Avg | $3.74 |
| Avg Volume | $1.47M |
| Volume | 34.2K |
Performance Analysis
NEUTRALUPC presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:36 UTC
Back to Screener Export Report